Application 016822

Type
NDA
Sponsor
B BRAUN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FREAMINE 8.5%AMINO ACIDSINJECTABLE;INJECTION8.5% (8.5GM/100ML)NoNo
002FREAMINE II 8.5%AMINO ACIDSINJECTABLE;INJECTION8.5% (8.5GM/100ML)NoNo
003FREAMINE III 3% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDEINJECTABLE;INJECTION3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100MLNoNo
004FREAMINE III 8.5%AMINO ACIDSINJECTABLE;INJECTION8.5% (8.5GM/100ML)NoNo
005FREAMINE III 10%AMINO ACIDSINJECTABLE;INJECTION10% (10GM/100ML)NoNo
006FREAMINE HBC 6.9%AMINO ACIDSINJECTABLE;INJECTION6.9% (6.9GM/100ML)NoNo
007FREAMINE III 8.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATEINJECTABLE;INJECTION8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 7 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N016822-001FREAMINE 8.5%AMINO ACIDS8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982
N016822-002FREAMINE II 8.5%AMINO ACIDS8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982
N016822-003FREAMINE III 3% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100MLINJECTABLE / INJECTIONApproved before 1982
N016822-004FREAMINE III 8.5%AMINO ACIDS8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982
N016822-005FREAMINE III 10%AMINO ACIDS10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982
N016822-006FREAMINE HBC 6.9%AMINO ACIDS6.9% (6.9GM/100ML)INJECTABLE / INJECTION1983-05-17
N016822-007FREAMINE III 8.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLINJECTABLE / INJECTION1988-07-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 6 of 8 · 315 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2019-12-14 00:12 UTC2019-12N016822-005FREAMINE III 10%10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N016822-006FREAMINE HBC 6.9%6.9% (6.9GM/100ML)INJECTABLE / INJECTION1983-05-173f01610625f2…
2019-12-14 00:12 UTC2019-12N016822-007FREAMINE III 8.5% W/ ELECTROLYTES8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLINJECTABLE / INJECTION1988-07-013f01610625f2…
2019-09-15 20:21 UTC2019-09N016822-001FREAMINE 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N016822-002FREAMINE II 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N016822-003FREAMINE III 3% W/ ELECTROLYTES3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100MLINJECTABLE / INJECTIONApproved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N016822-004FREAMINE III 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N016822-005FREAMINE III 10%10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N016822-006FREAMINE HBC 6.9%6.9% (6.9GM/100ML)INJECTABLE / INJECTION1983-05-17b00525d2431f…
2019-09-15 20:21 UTC2019-09N016822-007FREAMINE III 8.5% W/ ELECTROLYTES8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLINJECTABLE / INJECTION1988-07-01b00525d2431f…
2019-07-19 19:46 UTC2019-07N016822-001FREAMINE 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N016822-002FREAMINE II 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N016822-003FREAMINE III 3% W/ ELECTROLYTES3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100MLINJECTABLE / INJECTIONApproved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N016822-004FREAMINE III 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N016822-005FREAMINE III 10%10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N016822-006FREAMINE HBC 6.9%6.9% (6.9GM/100ML)INJECTABLE / INJECTION1983-05-17ea99ee380514…
2019-07-19 19:46 UTC2019-07N016822-007FREAMINE III 8.5% W/ ELECTROLYTES8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLINJECTABLE / INJECTION1988-07-01ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016822-001FREAMINE 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016822-002FREAMINE II 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016822-003FREAMINE III 3% W/ ELECTROLYTES3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100MLINJECTABLE / INJECTIONApproved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016822-004FREAMINE III 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016822-005FREAMINE III 10%10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016822-006FREAMINE HBC 6.9%6.9% (6.9GM/100ML)INJECTABLE / INJECTION1983-05-176a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016822-007FREAMINE III 8.5% W/ ELECTROLYTES8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLINJECTABLE / INJECTION1988-07-016a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N016822-001FREAMINE 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N016822-002FREAMINE II 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N016822-003FREAMINE III 3% W/ ELECTROLYTES3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100MLINJECTABLE / INJECTIONApproved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N016822-004FREAMINE III 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N016822-005FREAMINE III 10%10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N016822-006FREAMINE HBC 6.9%6.9% (6.9GM/100ML)INJECTABLE / INJECTION1983-05-171c564ffb4f44…
2024-02-18 07:12 UTC2024-02N016822-007FREAMINE III 8.5% W/ ELECTROLYTES8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLINJECTABLE / INJECTION1988-07-011c564ffb4f44…
2023-12-20 04:57 UTC2023-12N016822-001FREAMINE 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N016822-002FREAMINE II 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N016822-003FREAMINE III 3% W/ ELECTROLYTES3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100MLINJECTABLE / INJECTIONApproved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N016822-004FREAMINE III 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N016822-005FREAMINE III 10%10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N016822-006FREAMINE HBC 6.9%6.9% (6.9GM/100ML)INJECTABLE / INJECTION1983-05-17ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N016822-007FREAMINE III 8.5% W/ ELECTROLYTES8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100MLINJECTABLE / INJECTION1988-07-01ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N016822-001FREAMINE 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N016822-002FREAMINE II 8.5%8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982a72a2bbeb626…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0264-9010FreAmine IIIISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, PHOSPHORIC ACID, and SODIUM BISULFITEB. Braun Medical Inc.NDACurrent
0264-9010FreAmine IIIISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, PHOSPHORIC ACID, and SODIUM BISULFITEB. Braun Medical Inc.NDACurrent
0264-9010FreAmine IIIISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, PHOSPHORIC ACID, and SODIUM BISULFITEB. Braun Medical Inc.NDACurrent
0264-9350FreAmine HBCISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, and SODIUM BISULFITEB. Braun Medical Inc.NDACurrent
0264-9350FreAmine HBCISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, and SODIUM BISULFITEB. Braun Medical Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
33200SUPPL2004-06-01
13038SUPPL2004-06-01